Hypertension, commonly known as high blood pressure, remains one of the most widespread chronic medical conditions globally, affecting over a billion people and standing as a major risk factor for cardiovascular disease, stroke, and kidney failure. Managing blood pressure requires long-term therapeutic interventions, lifestyle modifications, and reliable pharmaceutical formulations. Among the...

The global pharmaceutical industry continues to witness steady expansion as the prevalence of cardiovascular diseases and hypertension rises across both developed and emerging economies. Nitrendipine, a calcium channel blocker widely prescribed for the management of hypertension and angina, remains an important therapeutic option in cardiovascular care. The drug works by relaxing blood vessels,...

According to the latest report published by Data Bridge Market Research, the Glomerulonephritis Market  CAGR Value The global glomerulonephritis market size was valued at USD 12.17 billion in 2025 and is expected to reach USD 17.57 billion by 2033, at a CAGR of 4.70% during the forecast period This Glomerulonephritis Market research report is prepared with detailed...